Búsqueda | Portal de Búsqueda de la BVS

1.

Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based nonintensive therapy.

Othman, Jad; Tiong, Ing S; O'Nions, Jenny; Dennis, Mike; Mokretar, Katya; Ivey, Adam; Austin, Michael; Latif, Anne-Louise; Amer, Mariam; Chan, Wei Yee; Crawley, Charles; Crolla, Francesca; Cross, Joe; Dang, Ray; Elliot, Johnathon; Fong, Chun Y; Galli, Sofia; Gallipoli, Paolo; Hogan, Francesca; Kalkur, Pallavi; Khan, Anjum; Krishnamurthy, Pramila; Laurie, John; Loo, Sun; Marshall, Scott; Mehta, Priyanka; Murthy, Vidhya; Nagumantry, Sateesh; Pillai, Srinivas; Potter, Nicola; Sellar, Rob; Taylor, Tom; Zhao, Rui; Russell, Nigel H; Wei, Andrew H; Dillon, Richard.

Blood ; 143(4): 336-341, 2024 Jan 25.

Artículo en Inglés | MEDLINE | ID: mdl-37647641

2.

TP53 status and impact on AML prognosis within the ELN 2022 risk classification.

Fleming, Shaun; Tsai, Xavier Cheng-Hong; Morris, Rhiannon; Hou, Hsin-An; Wei, Andrew H.

Blood ; 142(23): 2029-2033, 2023 12 07.

Artículo en Inglés | MEDLINE | ID: mdl-37647854

3.

Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia.

Moujalled, Donia M; Brown, Fiona C; Chua, Chong Chyn; Dengler, Michael A; Pomilio, Giovanna; Anstee, Natasha S; Litalien, Veronique; Thompson, Ella; Morley, Thomas; MacRaild, Sarah; Tiong, Ing S; Morris, Rhiannon; Dun, Karen; Zordan, Adrian; Shah, Jaynish; Banquet, Sebastien; Halilovic, Ensar; Morris, Erick; Herold, Marco J; Lessene, Guillaume; Adams, Jerry M; Huang, David C S; Roberts, Andrew W; Blombery, Piers; Wei, Andrew H.

Blood ; 141(6): 634-644, 2023 02 09.

Artículo en Inglés | MEDLINE | ID: mdl-36219880

4.

Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial.

de Botton, Stéphane; Montesinos, Pau; Schuh, Andre C; Papayannidis, Cristina; Vyas, Paresh; Wei, Andrew H; Ommen, Hans; Semochkin, Sergey; Kim, Hee-Je; Larson, Richard A; Koprivnikar, Jaime; Frankfurt, Olga; Thol, Felicitas; Chromik, Jörg; Byrne, Jenny; Pigneux, Arnaud; Thomas, Xavier; Salamero, Olga; Vidriales, Maria Belen; Doronin, Vadim; Döhner, Hartmut; Fathi, Amir T; Laille, Eric; Yu, Xin; Hasan, Maroof; Martin-Regueira, Patricia; DiNardo, Courtney D.

Blood ; 141(2): 156-167, 2023 01 12.

Artículo en Inglés | MEDLINE | ID: mdl-35714312

5.

Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes.

Zeidan, Amer M; Platzbecker, Uwe; Bewersdorf, Jan Philipp; Stahl, Maximilian; Adès, Lionel; Borate, Uma; Bowen, David; Buckstein, Rena; Brunner, Andrew; Carraway, Hetty E; Daver, Naval; Díez-Campelo, Maria; de Witte, Theo; DeZern, Amy E; Efficace, Fabio; Garcia-Manero, Guillermo; Garcia, Jacqueline S; Germing, Ulrich; Giagounidis, Aristoteles; Griffiths, Elizabeth A; Hasserjian, Robert P; Hellström-Lindberg, Eva; Iastrebner, Marcelo; Komrokji, Rami; Kulasekararaj, Austin G; Malcovati, Luca; Miyazaki, Yasushi; Odenike, Olatoyosi; Santini, Valeria; Sanz, Guillermo; Scheinberg, Phillip; Stauder, Reinhard; van de Loosdrecht, Arjan A; Wei, Andrew H; Sekeres, Mikkael A; Fenaux, Pierre.

Blood ; 141(17): 2047-2061, 2023 04 27.

Artículo en Inglés | MEDLINE | ID: mdl-36724453

6.

Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG.

Loo, Sun; Roberts, Andrew W; Anstee, Natasha S; Kennedy, Glen A; He, Simon; Schwarer, Anthony P; Enjeti, Anoop K; D'Rozario, James; Marlton, Paula; Bilmon, Ian A; Taper, John; Cull, Gavin; Tiley, Campbell; Verner, Emma; Hahn, Uwe; Hiwase, Devendra K; Iland, Harry J; Murphy, Nick; Ramanathan, Sundra; Reynolds, John; Ong, Doen Ming; Tiong, Ing Soo; Wall, Meaghan; Murray, Michael; Rawling, Tristan; Leadbetter, Joanna; Rowley, Leesa; Latimer, Maya; Yuen, Sam; Ting, Stephen B; Fong, Chun Yew; Morris, Kirk; Bajel, Ashish; Seymour, John F; Levis, Mark J; Wei, Andrew H.

Blood ; 142(23): 1960-1971, 2023 12 07.

Artículo en Inglés | MEDLINE | ID: mdl-37647654

7.

Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML-001.

Ravandi, Farhad; Döhner, Hartmut; Wei, Andrew H; Montesinos, Pau; Pfeilstöcker, Michael; Papayannidis, Cristina; Lai, Yinzhi; Wang, Kefeng; See, Wendy L; de Menezes, Daniel Lopes; Petrlik, Erica; Prebet, Thomas; Roboz, Gail J.

Br J Haematol ; 204(3): 877-886, 2024 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-37952982

8.

Acute myeloid leukaemia.

DiNardo, Courtney D; Erba, Harry P; Freeman, Sylvie D; Wei, Andrew H.

Lancet ; 401(10393): 2073-2086, 2023 06 17.

Artículo en Inglés | MEDLINE | ID: mdl-37068505

9.

Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidine.

Döhner, Hartmut; Wei, Andrew H; Roboz, Gail J; Montesinos, Pau; Thol, Felicitas R; Ravandi, Farhad; Dombret, Hervé; Porkka, Kimmo; Sandhu, Irwindeep; Skikne, Barry; See, Wendy L; Ugidos, Manuel; Risueño, Alberto; Chan, Esther T; Thakurta, Anjan; Beach, C L; Lopes de Menezes, Daniel.

Blood ; 140(15): 1674-1685, 2022 10 13.

Artículo en Inglés | MEDLINE | ID: mdl-35960871

10.

Oral azacitidine prolongs survival of patients with AML in remission independently of measurable residual disease status.

Roboz, Gail J; Ravandi, Farhad; Wei, Andrew H; Dombret, Hervé; Thol, Felicitas; Voso, Maria Teresa; Schuh, Andre C; Porkka, Kimmo; La Torre, Ignazia; Skikne, Barry; Zhong, Jianhua; Beach, C L; Risueño, Alberto; Menezes, Daniel L; Ossenkoppele, Gert; Döhner, Hartmut.

Blood ; 139(14): 2145-2155, 2022 04 07.

Artículo en Inglés | MEDLINE | ID: mdl-34995344

11.

Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL.

Blombery, Piers; Lew, Thomas E; Dengler, Michael A; Thompson, Ella R; Lin, Victor S; Chen, Xiangting; Nguyen, Tamia; Panigrahi, Ashish; Handunnetti, Sasanka M; Carney, Dennis A; Westerman, David A; Tam, Constantine S; Adams, Jerry M; Wei, Andrew H; Huang, David C S; Seymour, John F; Roberts, Andrew W; Anderson, Mary Ann.

Blood ; 139(8): 1198-1207, 2022 02 24.

Artículo en Inglés | MEDLINE | ID: mdl-34469514

12.

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.

Döhner, Hartmut; Wei, Andrew H; Appelbaum, Frederick R; Craddock, Charles; DiNardo, Courtney D; Dombret, Hervé; Ebert, Benjamin L; Fenaux, Pierre; Godley, Lucy A; Hasserjian, Robert P; Larson, Richard A; Levine, Ross L; Miyazaki, Yasushi; Niederwieser, Dietger; Ossenkoppele, Gert; Röllig, Christoph; Sierra, Jorge; Stein, Eytan M; Tallman, Martin S; Tien, Hwei-Fang; Wang, Jianxiang; Wierzbowska, Agnieszka; Löwenberg, Bob.

Blood ; 140(12): 1345-1377, 2022 09 22.

Artículo en Inglés | MEDLINE | ID: mdl-35797463

13.

Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM-3 antibody, in combination with decitabine or azacitidine in high- or very high-risk myelodysplastic syndromes.

Brunner, Andrew M; Esteve, Jordi; Porkka, Kimmo; Knapper, Steve; Traer, Elie; Scholl, Sebastian; Garcia-Manero, Guillermo; Vey, Norbert; Wermke, Martin; Janssen, Jeroen J W M; Narayan, Rupa; Fleming, Shaun; Loo, Sun; Tovar, Natalia; Kontro, Mika; Ottmann, Oliver G; Naidu, Purushotham; Sun, Haiying; Han, May; White, Roisin; Zhang, Na; Mohammed, Anisa; Sabatos-Peyton, Catherine A; Steensma, David P; Rinne, Mikael L; Borate, Uma M; Wei, Andrew H.

Am J Hematol ; 99(2): E32-E36, 2024 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-37994196

14.

TP53-altered acute myeloid leukemia and myelodysplastic syndrome with excess blasts should be approached as a single entity.

Shallis, Rory M; Daver, Naval G; Altman, Jessica K; Hasserjian, Robert P; Kantarjian, Hagop M; Platzbecker, Uwe; Santini, Valeria; Wei, Andrew H; Sallman, David A; Zeidan, Amer M.

Cancer ; 129(2): 175-180, 2023 01 15.

Artículo en Inglés | MEDLINE | ID: mdl-36397669

15.

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission.

Wei, Andrew H; Döhner, Hartmut; Pocock, Christopher; Montesinos, Pau; Afanasyev, Boris; Dombret, Hervé; Ravandi, Farhad; Sayar, Hamid; Jang, Jun-Ho; Porkka, Kimmo; Selleslag, Dominik; Sandhu, Irwindeep; Turgut, Mehmet; Giai, Valentina; Ofran, Yishai; Kizil Çakar, Merih; Botelho de Sousa, Aida; Rybka, Justyna; Frairia, Chiara; Borin, Lorenza; Beltrami, Germana; Cermák, Jaroslav; Ossenkoppele, Gert J; La Torre, Ignazia; Skikne, Barry; Kumar, Keshava; Dong, Qian; Beach, C L; Roboz, Gail J.

N Engl J Med ; 383(26): 2526-2537, 2020 12 24.

Artículo en Inglés | MEDLINE | ID: mdl-33369355

16.

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia.

DiNardo, Courtney D; Jonas, Brian A; Pullarkat, Vinod; Thirman, Michael J; Garcia, Jacqueline S; Wei, Andrew H; Konopleva, Marina; Döhner, Hartmut; Letai, Anthony; Fenaux, Pierre; Koller, Elizabeth; Havelange, Violaine; Leber, Brian; Esteve, Jordi; Wang, Jianxiang; Pejsa, Vlatko; Hájek, Roman; Porkka, Kimmo; Illés, Árpád; Lavie, David; Lemoli, Roberto M; Yamamoto, Kazuhito; Yoon, Sung-Soo; Jang, Jun-Ho; Yeh, Su-Peng; Turgut, Mehmet; Hong, Wan-Jen; Zhou, Ying; Potluri, Jalaja; Pratz, Keith W.

N Engl J Med ; 383(7): 617-629, 2020 08 13.

Artículo en Inglés | MEDLINE | ID: mdl-32786187

17.

BCL2 and MCL1 inhibitors for hematologic malignancies.

Roberts, Andrew W; Wei, Andrew H; Huang, David C S.

Blood ; 138(13): 1120-1136, 2021 09 30.

Artículo en Inglés | MEDLINE | ID: mdl-34320168

18.

Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias.

Thijssen, Rachel; Diepstraten, Sarah T; Moujalled, Donia; Chew, Edward; Flensburg, Christoffer; Shi, Melissa X; Dengler, Michael A; Litalien, Veronique; MacRaild, Sarah; Chen, Maoshan; Anstee, Natasha S; Reljic, Boris; Gabriel, Sarah S; Djajawi, Tirta M; Riffkin, Chris D; Aubrey, Brandon J; Chang, Catherine; Tai, Lin; Xu, Zhen; Morley, Thomas; Pomilio, Giovanna; Bruedigam, Claudia; Kallies, Axel; Stroud, David A; Bajel, Ashish; Kluck, Ruth M; Lane, Steven W; Schoumacher, Marie; Banquet, Sébastien; Majewski, Ian J; Strasser, Andreas; Roberts, Andrew W; Huang, David C S; Brown, Fiona C; Kelly, Gemma L; Wei, Andrew H.

Blood ; 137(20): 2721-2735, 2021 05 20.

Artículo en Inglés | MEDLINE | ID: mdl-33824975

19.

Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower-intensity therapy: Roadmap from an ELN-DAVID expert panel.

Ravandi, Farhad; Cloos, Jacqueline; Buccisano, Francesco; Dillon, Richard; Döhner, Konstanze; Freeman, Sylvie D; Hourigan, Christopher S; Ossenkoppele, Gerrit J; Roboz, Gail J; Subklewe, Marion; Thiede, Christian; Arnhardt, Isabell; Valk, Peter J M; Venditti, Adriano; Wei, Andrew H; Walter, Roland B; Heuser, Michael.

Am J Hematol ; 98(12): 1847-1855, 2023 12.

Artículo en Inglés | MEDLINE | ID: mdl-37671649

20.

Enhancing our chances of picking a winner in higher-risk myelodysplastic syndromes.

Wei, Andrew H; Seymour, John F.

Br J Haematol ; 198(3): 415-418, 2022 08.

Artículo en Inglés | MEDLINE | ID: mdl-35544384

Portal de Búsqueda de la BVS

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: